Skip to main content
. 2010 Jan;3(1):15–28. doi: 10.1177/1756285609353354

Figure 2.

Figure 2.

Least square means of combined active lesions, gadolinium (Gd)-enhancing lesions, and T2 lesions over time adjusted by respective baseline at day 0. There was no significant treatment effect observed for new T2 active lesions (p = 0.1), new active Gd lesions (p = 0.29), or for combined active lesions (CAL) (p = 0.15).